Cyclo Therapeutics Stock Beta

CYTHW Stock  USD 0.13  0.01  7.14%   
Cyclo Therapeutics fundamentals help investors to digest information that contributes to Cyclo Therapeutics' financial success or failures. It also enables traders to predict the movement of Cyclo Stock. The fundamental analysis module provides a way to measure Cyclo Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cyclo Therapeutics stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Cyclo Therapeutics Company Beta Analysis

Cyclo Therapeutics' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Beta

 = 

Covariance

Variance

More About Beta | All Equity Analysis

Current Cyclo Therapeutics Beta

    
  -0.38  
Most of Cyclo Therapeutics' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cyclo Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Cyclo Beta Driver Correlations

Understanding the fundamental principles of building solid financial models for Cyclo Therapeutics is extremely important. It helps to project a fair market value of Cyclo Stock properly, considering its historical fundamentals such as Beta. Since Cyclo Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cyclo Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cyclo Therapeutics' interrelated accounts and indicators.
0.85-0.96-0.710.810.680.730.990.4-0.28-0.42-0.3-0.520.80.70.910.9-0.79-0.670.65-0.48
0.85-0.89-0.30.450.790.280.84-0.04-0.23-0.43-0.23-0.330.450.530.950.95-0.65-0.390.30.01
-0.96-0.890.63-0.79-0.74-0.62-0.98-0.220.20.370.220.63-0.73-0.72-0.96-0.950.770.58-0.530.32
-0.71-0.30.63-0.91-0.3-0.94-0.74-0.820.240.290.280.7-0.98-0.65-0.46-0.440.770.89-0.920.72
0.810.45-0.79-0.910.440.930.850.58-0.24-0.13-0.27-0.760.910.760.610.59-0.67-0.710.75-0.67
0.680.79-0.74-0.30.440.230.7-0.14-0.25-0.07-0.25-0.460.410.310.790.8-0.38-0.450.310.03
0.730.28-0.62-0.940.930.230.730.79-0.23-0.21-0.28-0.550.910.630.440.42-0.63-0.760.86-0.85
0.990.84-0.98-0.740.850.70.730.38-0.24-0.39-0.26-0.630.830.730.920.91-0.81-0.680.65-0.46
0.4-0.04-0.22-0.820.58-0.140.790.38-0.18-0.29-0.22-0.280.760.340.050.02-0.54-0.750.82-0.77
-0.28-0.230.20.24-0.24-0.25-0.23-0.24-0.18-0.330.990.34-0.21-0.18-0.13-0.130.170.18-0.180.08
-0.42-0.430.370.29-0.13-0.07-0.21-0.39-0.29-0.33-0.31-0.08-0.41-0.3-0.48-0.480.710.45-0.380.12
-0.3-0.230.220.28-0.27-0.25-0.28-0.26-0.220.99-0.310.35-0.24-0.21-0.13-0.120.190.22-0.250.1
-0.52-0.330.630.7-0.76-0.46-0.55-0.63-0.280.34-0.080.35-0.68-0.58-0.46-0.460.570.54-0.490.27
0.80.45-0.73-0.980.910.410.910.830.76-0.21-0.41-0.24-0.680.690.60.58-0.85-0.910.89-0.66
0.70.53-0.72-0.650.760.310.630.730.34-0.18-0.3-0.21-0.580.690.610.6-0.68-0.460.46-0.26
0.910.95-0.96-0.460.610.790.440.920.05-0.13-0.48-0.13-0.460.60.611.0-0.73-0.490.4-0.18
0.90.95-0.95-0.440.590.80.420.910.02-0.13-0.48-0.12-0.460.580.61.0-0.72-0.480.38-0.15
-0.79-0.650.770.77-0.67-0.38-0.63-0.81-0.540.170.710.190.57-0.85-0.68-0.73-0.720.78-0.690.35
-0.67-0.390.580.89-0.71-0.45-0.76-0.68-0.750.180.450.220.54-0.91-0.46-0.49-0.480.78-0.950.51
0.650.3-0.53-0.920.750.310.860.650.82-0.18-0.38-0.25-0.490.890.460.40.38-0.69-0.95-0.66
-0.480.010.320.72-0.670.03-0.85-0.46-0.770.080.120.10.27-0.66-0.26-0.18-0.150.350.51-0.66
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition

In accordance with the recently published financial statements, Cyclo Therapeutics has a Beta of -0.381. This is much lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The beta for all United States stocks is notably higher than that of the company.

Cyclo Beta Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cyclo Therapeutics' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cyclo Therapeutics could also be used in its relative valuation, which is a method of valuing Cyclo Therapeutics by comparing valuation metrics of similar companies.
Cyclo Therapeutics is currently under evaluation in beta category among its peers.
As returns on the market increase, returns on owning Cyclo Therapeutics are expected to decrease at a much lower rate. During the bear market, Cyclo Therapeutics is likely to outperform the market.

Cyclo Fundamentals

About Cyclo Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Cyclo Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cyclo Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cyclo Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cyclo Stock Analysis

When running Cyclo Therapeutics' price analysis, check to measure Cyclo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclo Therapeutics is operating at the current time. Most of Cyclo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cyclo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyclo Therapeutics' price. Additionally, you may evaluate how the addition of Cyclo Therapeutics to your portfolios can decrease your overall portfolio volatility.